PureTech Health (LON:PRTC) Stock Price Up 14.6% – Here’s Why

PureTech Health plc (LON:PRTC)’s share price shot up 14.6% during trading on Friday . The company traded as high as GBX 118 ($1.53) and last traded at GBX 118 ($1.53). 1,623,564 shares traded hands during trading, an increase of 54% from the average session volume of 1,056,594 shares. The stock had previously closed at GBX 103 ($1.34).

Analysts Set New Price Targets

Separately, Jefferies Financial Group reissued a “buy” rating and issued a GBX 455 ($5.91) price objective on shares of PureTech Health in a research report on Monday, December 16th.

PureTech Health Trading Up 14.6 %

The company has a quick ratio of 2.51, a current ratio of 3.68 and a debt-to-equity ratio of 45.82. The firm has a market cap of £354.45 million, a P/E ratio of -4.84 and a beta of 1.02. The firm’s 50-day simple moving average is GBX 135.83 and its 200 day simple moving average is GBX 148.25.

PureTech Health Company Profile

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.